474 — Aceso Life Science Share Price
0.000.00%
Last trade - 00:00- HK$1.11bn
- HK$4.00bn
- HK$312.00m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.87 | ||
| Price to Tang. Book | 1.01 | ||
| Price to Free Cashflow | 23.07 | ||
| Price to Sales | 4.19 | ||
| EV to EBITDA | 22.97 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.78% | ||
| Return on Equity | -28.43% | ||
| Operating Margin | -43.18% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 319.51 | 295.64 | 346 | 315 | 312 | n/a | n/a | -1.12% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aceso Life Science Group Ltd is an investment holding company engaged in the sale of construction machinery and spare parts. The Company operates its business through six segments. Rental and Sales of Construction Machinery and Spare Parts segment engages in the sale of construction machinery, spare parts and construction materials, and provision of construction machinery rental services. Property Leasing segment engages in the leasing of commercial properties. Money Lending segment provides mortgage loans and personal loans in Hong Kong. Provision of Asset Management, Securities Brokerage, Commodities, Futures and Other Financial Services segment engages in the securities, futures trading, asset management, wealth management and others. Provision of Repair and Maintenance and Transportation Services segment provides repair and maintenance services of construction machinery and transportation services. Property Development segment engages in the development of property.
Directors
- Chi Tak Fok CFO (41)
- Chan Lai Ping GCN
- Zhiliang Ou EDR (46)
- Hai Ying Xu EDR (63)
- Ming Sun Chan NID (48)
- Kwan Sing Lam NID (51)
- Yiu Tong Mak NID (61)
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- September 30th, 2005
- Public Since
- June 6th, 2006
- No. of Employees
- 142
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 7,382,000,000
- Address
- Unit 4803, 48/F, COSCO Tower
- Web
- http://www.acesogrouphk.com/
- Phone
- +852 null31608466
- Auditors
- ZHONGHUI ANDA CPA Limited
Upcoming Events for 474
Aceso Life Science Group Ltd Annual Shareholders Meeting
Similar to 474
Acme International Holdings
Stock Exchange of Hong Kong Limited
Best Linking group
Stock Exchange of Hong Kong Limited
Bortex Global
Stock Exchange of Hong Kong Limited
CALB Co
Stock Exchange of Hong Kong Limited
Chen Hsong Holdings
Stock Exchange of Hong Kong Limited
FAQ
What is the Aceso Life Science share price?
As of Today at 19:00 UTC, shares in Aceso Life Science are trading at HK$0.15. This share price information is delayed by 15 minutes.
How has the Aceso Life Science share price performed this year?
Shares in Aceso Life Science last closed at HK$0.15 and the price had moved by -6.83% over the past 365 days. In terms of relative price strength the Aceso Life Science share price has underperformed the FTSE Developed Asia Pacific Index by -6.19% over the past year.
What are the analyst and broker recommendations for Aceso Life Science?
There is no consensus recommendation for this security.
What is the Aceso Life Science dividend yield?
Aceso Life Science does not currently pay a dividend.
Does Aceso Life Science pay a dividend?
Aceso Life Science does not currently pay a dividend.
When does Aceso Life Science next pay dividends?
Aceso Life Science does not currently pay a dividend.
How do I buy Aceso Life Science shares?
To buy shares in Aceso Life Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aceso Life Science?
As of the previous close price of HK$0.15, shares in Aceso Life Science had a market capitalisation of HK$1.11bn.
Where are Aceso Life Science shares listed?
Here are the trading details for Aceso Life Science:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 474
What kind of share is Aceso Life Science?
Based on an overall assessment of its quality, value and momentum Aceso Life Science is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aceso Life Science share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Aceso Life Science share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aceso Life Science. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +0.01%.
As of the last closing price of HK$0.15, shares in Aceso Life Science were trading +2.38% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aceso Life Science PE Ratio?
The Aceso Life Science PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aceso Life Science?
Aceso Life Science's management team is headed by:
- Chi Tak Fok - CFO
- Chan Lai Ping - GCN
- Zhiliang Ou - EDR
- Hai Ying Xu - EDR
- Ming Sun Chan - NID
- Kwan Sing Lam - NID
- Yiu Tong Mak - NID